Total planned funding: $425,628,679
Allocations
Countries/Regions
Eswatini | $425,628,679 |
Organizational Types
Private Contractor | $101,971,390 |
Unknown | $81,873,063 |
NGO | $78,919,901 |
University | $70,360,611 |
Own Agency | $52,238,895 |
FBO | $13,230,009 |
Host Country Government Agency | $12,894,827 |
Multi-lateral Agency | $9,889,694 |
Other USG Agency | $4,030,689 |
Implementing Agency | $219,600 |
Program Areas
Care | $126,110,845 |
Treatment | $101,238,878 |
Prevention | $84,287,701 |
Governance and Systems | $50,193,373 |
Management and Operations | $32,011,387 |
Testing | $31,786,495 |
Budget Codes
HTXS: Treatment: Adult Treatment | $80,653,172 |
HBHC: Care: Adult Care and Support | $50,638,116 |
HKID: Care: Orphans and Vulnerable Children | $42,125,970 |
HVMS: Management and Operations | $32,011,387 |
HVCT: Testing: HIV Testing and Counseling | $31,786,495 |
HVOP: Sexual Prevention: Other Sexual Prevention | $29,404,064 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $25,219,114 |
HVSI: Strategic Information | $23,509,683 |
HVTB: Care: TB/HIV | $22,396,809 |
OHSS: Health Systems Strengthening | $18,576,363 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,068,743 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,203,809 |
HTXD: Treatment: ARV Drugs | $11,278,150 |
PDCS: Care: Pediatric Care and Support | $10,949,950 |
PDTX: Treatment: Pediatric Treatment | $9,307,556 |
HLAB: Laboratory Infrastructure | $8,107,327 |
HMBL: Biomedical Prevention: Blood Safety | $2,391,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$63,413,197
Countries/Regions
Columbia University:
$58,577,235
Countries/Regions
Pact, Inc.:
$48,620,654
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions